Literature DB >> 33184681

Elevated [68Ga]Ga-DOTA-FAPI-04 activity in degenerative osteophyte in a patient with lung cancer.

Huipan Liu1, Yingwei Wang1, Wei Zhang1, Liang Cai1, Yue Chen2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33184681     DOI: 10.1007/s00259-020-05090-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  2 in total

1.  IgG4-related disease revealed by 68Ga-FAPI and 18F-FDG PET/CT.

Authors:  Yaping Luo; Qingqing Pan; Wen Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-13       Impact factor: 9.236

2.  Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer.

Authors:  Haojun Chen; Yizhen Pang; Jingxun Wu; Liang Zhao; Bing Hao; Jing Wu; Jihong Wei; Siming Wu; Long Zhao; Zuoming Luo; Xuehua Lin; Chengrong Xie; Long Sun; Qin Lin; Hua Wu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-28       Impact factor: 9.236

  2 in total
  4 in total

Review 1.  Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond.

Authors:  Mengting Li; Muhsin H Younis; Yongxue Zhang; Weibo Cai; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-31       Impact factor: 10.057

2.  Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers.

Authors:  Junhao Wu; Yingwei Wang; Taiping Liao; Zijuan Rao; Weidong Gong; Lei Ou; Yue Chen; Chunyin Zhang
Journal:  Front Oncol       Date:  2021-09-17       Impact factor: 6.244

3.  FAPI-04 Uptake in Healthy Tissues of Cancer Patients in 68Ga-FAPI-04 PET/CT Imaging.

Authors:  Cihan Gündoğan; Yunus Güzel; Canan Can; İhsan Kaplan; Halil Kömek
Journal:  Contrast Media Mol Imaging       Date:  2021-11-23       Impact factor: 3.161

Review 4.  FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors.

Authors:  Tianshuo Yang; Long Ma; Haodong Hou; Feng Gao; Weijing Tao
Journal:  Front Oncol       Date:  2022-01-04       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.